U.S. federal trademark · Serial No. 77807473 · Reg. No. 3962527
Medical testing services that utilize a patent's clinical, molecular and morphometric information for predicting the probability of clinical failure post prostatectomy or biopsy in the absence of other treatment and predicting a patient's progression of disease and providing information useful to a doctor in prescribing a recommended therapy
Source: USPTO federal trademark records. Informational only, not legal advice. Status and details may lag the live USPTO database.